Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (131-140 of 4,670) with videos related to

Pageof 467
Sort By:
Cancer Discovery|August 17, 2021
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?Lisa Derosa, Bertrand Routy, Antoine Desilets, et al.
Cancer Discovery|August 6, 2021
Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLCKwan Ho Tang, Shuai Li, Alireza Khodadadi-Jamayran, et al.
Cancer Discovery|August 7, 2021
Ribosome ADP-Ribosylation Controls Protein Synthesis in Ovarian Cancer
Cancer Discovery|August 21, 2021
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic LeukemiaJianping Li, Julia Hlavka-Zhang, Jonathan H Shrimp, et al.
Cancer Discovery|August 21, 2021
PIN1 Inhibition Synergizes with Immunochemotherapy in Pancreatic Cancer
Cancer Discovery|May 22, 2021
cGAS-STING Pathway Activation in cDCs Underlies TIM3 Blockade Efficacy
Cancer Discovery|August 4, 2021
The gRASs Is Greener: Potential New Therapies in Lung Cancer with Acquired Resistance to KRAS<sup>G12C</sup> InhibitorsMarika Pinnelli, Livio Trusolino
Cancer Discovery|August 4, 2021
Chemerin Tips the Scales in ccRCC to Evade FerroptosisEd Reznik, Hui Jiang, A Ari Hakimi
Cancer Discovery|August 14, 2021
Amivantamab Is Active in Platinum-Resistant <i>EGFR</i> ex20-mutant NSCLC
Cancer Discovery|May 22, 2021
Durable Responses with Vemurafenib plus Rituximab in Hairy-Cell Leukemia
Pageof 467

Showing results (131-140 of 4,670) with videos related to

Sort By:
Pageof 467
Cancer Discovery|August 17, 2021
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?Lisa Derosa, Bertrand Routy, Antoine Desilets, et al.
Cancer Discovery|August 6, 2021
Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLCKwan Ho Tang, Shuai Li, Alireza Khodadadi-Jamayran, et al.
Cancer Discovery|August 7, 2021
Ribosome ADP-Ribosylation Controls Protein Synthesis in Ovarian Cancer
Cancer Discovery|August 21, 2021
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic LeukemiaJianping Li, Julia Hlavka-Zhang, Jonathan H Shrimp, et al.
Cancer Discovery|August 21, 2021
PIN1 Inhibition Synergizes with Immunochemotherapy in Pancreatic Cancer
Cancer Discovery|May 22, 2021
cGAS-STING Pathway Activation in cDCs Underlies TIM3 Blockade Efficacy
Cancer Discovery|August 4, 2021
The gRASs Is Greener: Potential New Therapies in Lung Cancer with Acquired Resistance to KRAS<sup>G12C</sup> InhibitorsMarika Pinnelli, Livio Trusolino
Cancer Discovery|August 4, 2021
Chemerin Tips the Scales in ccRCC to Evade FerroptosisEd Reznik, Hui Jiang, A Ari Hakimi
Cancer Discovery|August 14, 2021
Amivantamab Is Active in Platinum-Resistant <i>EGFR</i> ex20-mutant NSCLC
Cancer Discovery|May 22, 2021
Durable Responses with Vemurafenib plus Rituximab in Hairy-Cell Leukemia
Pageof 467